🇺🇸 FDA
Patent

US 11730716

Compounds for treating ophthalmic diseases and disorders

granted A61KA61K31/196A61K31/277

Quick answer

US patent 11730716 (Compounds for treating ophthalmic diseases and disorders) held by KIORA PHARMACEUTICALS GmbH expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KIORA PHARMACEUTICALS GmbH
Grant date
Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/196, A61K31/277, A61K31/341, A61K31/381